News & Events
Read more VitroScan's micro-tumor test accurately predicts chemotherapy response for ovarian cancer patients
9 September 2025
VitroScan is proud to announce the publication of a study showing its 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.
Read more
Read more VitroScan awarded ~ 200k Leap Medical:Forge grant
22 April 2025
We are very pleased to announce that VitroScan has received a grant of approximately 200k Euros from leap:up. The grant is part of the medical:forge Leipzig accelerator program, based in Leipzig, Germany.
Read more
Read more 'Hoe maak je het?' bij VitroScan
15 January 2025
Het Leidse radiostation Sleutelstad stuurde verslaggever Gerry van Bakel van het programma ‘Kennismakers’ naar VitroScan voor de rubriek ‘Hoe maak je het?’
Read more
Read more VitroScan awarded €1.9M by Biotech Booster to deliver chemotherapy response prediction for ovarian cancer patients
25 November 2024
VitroScan has developed ChemoPredict™, a predictive tumor testing service that revolutionizes treatment options for ovarian cancer patients.
Read more